{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2008"],"condition":["Metastatic adenocarcinoma of colon or rectum","Metastatic colorectal cancer"],"disease":["Metastatic Colorectal Cancer","Metastatic Adenocarcinoma Of Colon Or Rectum"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2524137"],"location":["Italy"],"study_start_month":["6"],"keyword":["UFT","Calcium levofolinate","ELOXATIN","ERBITUX"],"repository":["ECRIN MDR"],"study_status":["Terminated"],"additional_accession":[]},"is_claimable":false,"name":"First Line UFT, OXALIPLATIN and ERBITUX combination (TEGAFOX-E) in Elderly (≥ 70 years) metastatic colorectal patients: a Phase II ITMO study.","description":"Primary objectives: To assess the respons rate ORR (CR+PR)","dates":{"creation":"2008-06-15"},"accession":"2524137","cross_references":{"EU Clinical Trials Register":["2008-001355-21"]}}